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SUMMARY 
Nonsense Mediated mRNA Decay (NMD) is a translation-coupled mRNA surveillance 
mechanism which targets aberrant mRNAs harbouring premature termination codons (PTCs). 
This class of mutations would otherwise result in the translation of truncated proteins that 
could potentially be detrimental to the cell. Intriguingly, NMD is linked to pre-mRNA 
splicing: in mammalian cells PTCs induce strong NMD only in the presence of a downstream 
intron. In these systems, the link between pre-mRNA splicing and NMD is thought to be 
mediated by the Exon-Junction-Complex (EJC), which is a multiprotein complex that marks 
splice junctions.  
In fission yeast Schizosaccharomyces pombe, pre-mRNA splicing can also enhance NMD 
however this mechanism does not require the EJC. To gain further insight into the 
mechanisms of NMD I undertook a genome-wide screen to identify and characterize 
additional factors that may be involved in this process in fission yeast. In particular, I hoped 
to identify genes required for the link between splicing and NMD. The screen consisted of 
crossing a GFP reporter strain subject to NMD with haploid deletion mutants of 3,308 non-
essential genes in the S. pombe.  
Analysis of 2790 mutants identified 18 candidates. These were further characterised by 
northern blot analysis. From these 18 strains, 7 mutants look like genuine NMD mutants 
resembling the phenotype of known NMD genes. 5 genes have either direct or indirect links 
with splicing factors or the exosome-associated TRAMP complex. Future work will need to 
elucidate the molecular mechanism of the NMD phenotype and possible involvement of these 
genes in splicing, NMD and the TRAMP-mediated mRNA surveillance processes. 
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ABREVIATIONS AND ANNOTATIONS 
 
AS   Alternative Splicing 
APS   Ammonium persulphate 
Dd   Double distilled 
EJC    Exon Junction Complex 
LB   Lysogeny Broth 
NMD   Nonsense Mediated mRNA Decay 
Nmt   No message thiamine 
NZY   NZ Amine Yeast extract 
O/N   Overnight 
ORF   Open Reading Frame 
PEG   Polyethylene glycol 
PTC   Premature Termination Codon 
Rt   Room Temperature 
SDS   Sodium dodecyl sulphate 
SMG   Suppressor with morphological effect on genitalia 
St.   Sterilised 
UPF   Up-frameshift 
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CHAPTER I: INTRODUCTION 
1.1 Eukaryotic Gene Expression and Conservation of Genetic Fidelity  
Eukaryotic gene expression as defined by the Central Dogma of molecular biology proposed 
by Francis Crick in 1958 (Crick 1970) refers to the process of decoding of the genetic 
information into proteins.   
The general consensus is that transcription and translation are compartmentalised, with DNA 
being transcribed into a precursor messenger RNA (mRNA) intermediate within the nucleus 
by RNA polymerase II. During which it undergoes modification by the addition of a 5’-cap 
structure, 3’-end processing and polyadenylation to add the poly (A) tail, and removal of 
introns by the process of pre-mRNA splicing. The 5’ and 3’ modification are important for 
mRNA stability and have a role in translation initiation and termination. The mature mRNA 
is exported to the cytoplasm whereby it can sequentially bind the 40S and 60S ribosomal 
subunits and undergo translation by an elongation-competent 80S ribosome docked at the 
translation initiation codon. While translation is understood to be confined to the cytoplasm, 
it should be noted that a number of early studies concluded that this might happen also in the 
nucleus (Allfrey et al., 1957). In later studies, it has again been reported that amino acid 
incorporation can be visualised in the nucleus of permeabilised HeLa cells (Iborra 2001). In 
parallel, it has been reported that many ribosomal proteins and some translation factors are 
recruited to transcription sites at polytene chromosomes in Drosophila (Brogna, et al., 2002). 
The study in Drosophila also reported evidence of direct radioactive amino acid incorporation 
at transcription of intact cells sites and at the nucleolus. Most recently, visualisation of 
nascent polypeptide chains, also reveal their presence in the nucleus and nucleolus (David et 
al., 2012). Finally, using a novel technique to visualise the interaction between ribosomal 
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subunits, the Brogna lab has also found compelling evidence of functional nuclear 80S in 
Drosophila (manuscript submitted). 
1.2 Translation  
Translation initiation is a two-step process involving a minimum of nine eukaryotic initiation 
factors (eIFs) (Jackson 2010). The 40S ribosomal subunit, in conjunction with other factors, 
is understood to scan the 5’-3’ mRNA (as a 43S pre-initiation complex) to locate the start 
codon. The initiator Methionyl-transfer RNA (Met- tRNA) composes part of the 40S subunit 
by binding to the ribosomal peptidyl site (P site). Once this charged tRNA anticodon binds 
with the complementary AUG initiation codon, the 48S initiation complex is formed 
(Majumdar 2007). The second step in translation initiation is the binding of the 60S subunit 
to the 48S complex. This is achieved by the displacement of eIFs in the 48S initiation 
complex, or more specifically, that eIF5 and eIF5b hydrolyses and displaces eIF2-GTP, 
allowing 80S formation (Jackson 2010).  
Translation elongation may proceed in the presence of a complimenting amino acid 
containing tRNA (aminoacyl-tRNA), eukaryotic elongation factor eEF-1 and GTP to form a 
complex that can enter the vacant acceptor Site (A site) of the ribosome. Proofreading 
ensures that the correct anticodon is matched to the codon occupying the A site. Amino acids 
are coupled to their corresponding tRNA via an ester bond, which is catalysed by aminoacyl-
tRNA synthatase. The accuracy of this coupling is critical as the ribosome cannot distinguish 
between amino acids, only the tRNA anticodon. The ribosome subsequently catalyses the 
formation of a peptide bond between the new amino acid and the growing polypeptide in the 
P site (Jørgensen 2006; Capa 1998). It is understood that eIF-2 is responsible for the 
conformational changes in the ribosome, which possibly induces the mRNA movement by 
one codon sequentially, there is a co-ordinated movement of the tRNA’s, with the peptidyl-
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free tRNA displaced to the exit site (E site), allowing a new peptidyl-tRNA to translocate 
from the A site to the P site (Jørgensen 2006). This process is repeated until a termination 
codon is encountered. The three possible termination codons that will be encountered do not 
have a corresponding anticodon. Instead a eukaryotic release factors eRF-1 and eRF-3, a GTP 
binding protein, form a complex with the ribosome and catalyses the cleavage of the ester 
bond between the peptide and the final tRNA, releasing the newly synthesised polypeptide 
from the ribosome. Following the release of additional factors, the ribosome is recycled for 
another round of translation.  
1.3 Nonsense Mediated mRNA Decay  
The preservation of cellular function and therefore cell viability depends on genome integrity 
and its correct expression. It is the inevitable, that with such regulatory complexity, this 
fundamental system will be prone to high rates of error. Such fidelity is maintained by 
numerous decay pathways in order to safeguard the cell and these can initiate in both the 
nucleus and the cytoplasm to tightly regulate both transcription and translation. The most 
studied of these quality control decay mechanisms is the translation-coupled Nonsense 
Mediated Decay (NMD) (Jacobson 2007; Schweingruber et al., 2013).  
NMD is a quality control mechanism which is involved in the regulation of gene expression, 
specifically reducing the expression of aberrant mRNAs, which would otherwise result in the 
translation of truncated proteins that could potentially be detrimental to the cell. This 
surveillance mechanism has several different substrates, the most apparent being mRNAs that 
have acquired nonsense mutations. These can either be generated by point mutations or a 
frame-shift caused by deletions or insertions during DNA replication, transcription or as 
consequence of inefficient pre-mRNA processing, particularly during splicing (Amrani et al., 
5 
 
2006; Wen and Brogna, 2010). Nonsense mutations are changes in a triplet of bases that 
result in a premature termination codon (PTC) that constitutes either, UAG, UAA or UGA.  
A class of NMD substrates are aberrant mRNAs containing extended 3’UTRs, as a 
consequence of a mutation in the poly (A) site, can result in the use of cryptic 
polyadenylation sites further downstream as 3’ end formation sites.  
1.4 Trans-acting factors involved in NMD  
NMD is not a passive mechanism but requires a number of specific and conserved protein 
factors in order to distinguish between premature termination codons (PTCs) and normal stop 
codons (Amrani N 2006; Brogna S, Wen J 2009). NMD requires active translation and 
specific trans-acting factors, which include the core machinery composed of the Up-
frameshift (UPF) proteins, UPF1,-2 and -3. These factors were first identified in a genetic 
screen in S. cerevisiae (Culbertson 1980), and mutations or deletion of any of the UPF1-3 
genes have been seen to abolish NMD. UPF1 is an RNA binding protein with ATP dependant 
helicase activity (Cheng, Z et al 2007). It is understood that UPF1 forms a trimeric complex, 
with UPF2 bridging the interaction of UPF1 and -3. The UPF’s are essential for NMD in 
most cells (Amrani,  N 2006; Cheng, Z et al., 2007) and it is believed that it is this complex 
which links premature translation termination to mRNA degradation (Schweingruber et al., 
2013).  
 
Other known NMD factors include the SMG (suppressor with morphological effect on 
genitalia) proteins in higher eukaryotes. These are important for NMD in Caenorhabditis 
elegans and other higher eukaryotes; smg2, -3 and -4 are homologs of UPF1, -2 and -3 
respectively) (Conti & Izaurralde 2005). SMG1 is a protein kinase responsible for 
phosphorylating UPF1. In its phosphorylated state, UPF1 can bind specifically to the 
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prematurely terminating ribosome, this association is regulated by Smg 5 and -7 through 
dephosphorylation (Conti & Izaurralde 2005; Page et al., 1999). The interaction of UPF1 with 
UPF2 and the release factors induces mRNA decapping (Amrani et al., 2006), which triggers 
mRNA instability. The mRNA decay involves both exonucleolytic degradation directed from 
the ends of the nascent mRNA and endonucleolytic degradation in the vicinity of the PTC 
(Gatfield D & Izaurralde E 2004). The latter was understood to be the preferential process of 
degradation in Drosophila melanogaster while in both yeast and human cell, exonucleolytic 
degradation was thought to be favoured. Interestingly however Smg6 has since been 
identified as an endonuclease and implicated in the degradation of nonsense transcripts in 
both human and D. melanogaster cells (Eberle et al., 2009; Huntzinger et al., 2008).  
1.5 NMD mechanism: how PTCs are distinguished from normal stop 
codons  
Although the mechanism of differentiating PTCs from normal stop codons is not yet fully 
understood, several models have been proposed. Of the numerous models aiming to address 
the underlying mechanisms of NMD, conflicting evidence shows the inadequacies of all 
current explanations, or at least support the concept of species-specific divergence of what 
was once a conserved process. Initially, in mammalian cells a splicing dependent model 
based on the discovery of the EJC has been proposed; this defines the distance of the PTC 
from a splice site as a determining factor in PTC recognition. In support of this model, it was 
observed that in naturally intronless transcripts, the mRNA is not subject to NMD, but 
following the artificial insertion of an intron downstream of a normal termination codon, the 
wild-type stop codon is read as a PTC, resulting in reduced mRNA (Zhang 1998). 
However this does not fully explain all the observation and it has been in proposed that a key 
feature is, like in budding yeast, the distance between the PTC and the poly (A) tail. 
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Furthermore, a recent characterisation of the NMD phenomenon in S. pombe suggests that 
neither model can explain NMD in this organism.  Below I give a brief outline of the current 
models. 
1.6 The EJC model of NMD 
In mammalian cells, the link between splicing and NMD is thought to be mediated by the 
exon junction complex (EJC), a multi-protein complex (Wen and Brogna 2008; le Hir 
2000a/b). In human cells a minimum of five EJC components are required for NMD 
induction, these include; RNPS1, the heterodimer MAGOH:Y14, in addition to Barentsz and 
EIF4A111. The EJC is deposited by the spliceosome 20-24nt upstream of a splice junction 
and marks these boundaries as exon-exon junctions (Le Hir et al., 2001). 
As normal termination codons tend to reside within the terminal exon, it is thought that the 
EJC would be displaced by the translating ribosome, thus UPF1 is not activated and the 
mRNA will escape NMD. A stop codon situated >50-55 nucleotides upstream of the last 
splicing induced exon-exon junction, has been observed to trigger NMD (Izaurralde et al., 
2007; Lejeune and Maquat 2005), and is thought to be discriminated by the positional 
information provided by the EJC. During the pioneer round of translation, the first ribosome 
to encounter the PTC in this vicinity will initiate mRNA decay by the SURF complex 
(consisting of smg-1-upf1-eRF1-eRF3) (Kashima et al., 2006). The concept of a pioneer 
round of translation is that NMD occurs preferentially during the first translation round while 
the 5’ cap of the mRNA is still associated to the cap binding complex (CBC). The pioneer 
round is postulated to involve loading of one or more ribosomes and is biochemically 
distinguishable for the subsequent cycles of steady-state translation (Maquat 2010). The 
concept that NMD is restricted to the first translation cycle, remain however, controversial in 
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mammalian systems and there is no support for it in yeast (Amarani 2004; Keperwasser et al., 
2004).  
1.7 NMD polarity effect and the Faux 3’ UTR model 
Studies in initially in S. cerevisiae, but later also in Drosophila and mammalian cells, suggest 
that the distance between a stop codon and the 3’UTR is the key determinant in PTC 
recognition, and the Faux 3’ UTR was proposed. This model posits that normal translation to 
proceed the Poly (A) Binding Protein (PABP) is required to interact with the terminating 
ribosome and directly with eRF3, facilitating ribosome release from the mRNA. Should a 
termination codon occur ‘abnormally’ upstream, the increased distance reduces this 
interaction, allowing the core NMD factors, UPF proteins to instead interact with the 
terminating ribosome, thus facilitating NMD. 
In support of the above model, the artificial tethering of the poly (A) binding protein (pabp1) 
in yeast to a region downstream of the PTC leads to ‘normal’ translation termination without 
inducing NMD (Amrani 2004). pabp1 is a defining feature of the 3’UTR and possibly mimics 
the spatial arrangement between the normal termination codon and 3’UTR and suggests that 
pabp1 acts independently of 3’ end cleavage and polyadenylation. By interacting with eRF3 
the terminated ribosome is released from the mRNA as in the normal instance of termination 
(Izaurralde 2007). Consisting with this model is the observation that strong NMD is typically 
produced only by PTC located at the beginning of the coding region while those located 
further downstream are often immune. This polarity effect has been first detected in yeast, 
both S. cerevisiae and S. pombe, and in D. melanogaster (reviewed in Brogna & Wen, 2009; 
Wen and Brogna, 2010). But there are indications that it may also be occurring in mammalian 
cells (reviewed in Schweingruber et al., 2013). A strong indication that an abnormal long 
distance between the PTC and the poly (A) tail is a key NMD trigger in mammalian cells is 
9 
 
the observation that artificial folding of the poly (A) tail next to the PTC inhibits NMD 
(Eberle et al., 2008; Eberle et al., 2009). 
1.8 Project aims 
To gain further insight into the mechanisms of NMD, I will execute a genome wide screen of 
all non-essential genes in S. pombe, a powerful model organism allowing advanced molecular 
genetic manipulation, to identify and characterize any additional factors that may be involved 
in NMD in fission yeast.  The screen will consist of crossing a reporter strain expressing 
Green Fluorescent Protein (GFP) with the total 3,308 haploid deletion mutants from the S. 
pombe deletion library developed by Bioneer and KRIBB in Korea, representing 92.8% 
genome coverage.  
The reporter consists of a GFP ORF containing an intron insertion in the 3’ UTR, 
immediately after the normal termination codon, subsequently rendering this construct an 
NMD substrate. The expectation is that in the absence of any gene required for NMD, there 
will be a reduction or abolishment of the NMD mechanism, and the mRNA substrate will 
escape degradation. Thus any potential NMD factor can be screened based on an increase in 
the level of GFP expressed in relation to wild-type, and potentially comparative levels to 
those produced in the UPF1∆ strain. The mRNA levels will be quantified by Northern Blot 
analysis. 
While the screen will be unbiased, potentially it could identify genes involved in both 
splicing independent NMD, and splicing dependent NMD, the expectation for the latter is as 
a consequence of current literature, supporting splicing enhanced NMD (Wen J, Brogna S 
2010).  
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Figure 1:A. Schematic of PTC differentiation in invertebrate 
and yeast. 
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Figure 1:B. Schematic of PTC differentiation in mammalian cells. 
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Figure 1. Schematic of NMD substrate recognition models. 
A) In yeast and Drosophila: The Faux 3’UTR Model Splicing independent model 
postulates that, NMD is determined by the distance between the PTC and the 3’ poly (A) 
tail. Increased distance reduces the interaction of the terminating ribosome and poly (A) 
binding protein (PABP), allowing NMD factors to instead bind. In the case of normal 
termination, or if a PTC resides close to the 3’end, then NMD is not initiated and protein 
synthesis ensues.  B) In mammalian cells: The EJC Model Splicing dependent NMD 
model whereby NMD induction is dependent on the PTC residing upstream of the last 
occurring intron and is facilitated by the recruitment of the EJC complex to the 
terminating ribosome during pre-mRNA splicing facilitating NMD. During normal 
termination or in the instance when a PTC resides <50-55 nucleotides upstream of the 
last exon-exon junction, the EJC is displaced by the translating ribosome and NMD is not 
initiated. Protein synthesis proceeds.  
 
 
 
 
 
 
 
 
 
 
13 
 
CHAPTER II: MATERIALS AND METHODS 
2.1 Molecular Cloning and Bacterial Cell culture 
Refer to Appendix 1 for LB broth and LB agar recipe. 
Transformants were grown on either inverted 9cm LB agar plates in 37°C incubator (LEEC 
Incubator) or as liquid culture, overnight in rotating 37°C incubator (Innova 4000 Incubator 
Shaker) at 225 RPM. 
2.1.1 Rubidium Chloride chemi-competent cells  
E.coli (XL1-Blue) cells were rendered chemi-competent by the RB Cl method. 
1.  XL1-Blue cells were inoculated in 5ml of LB media and grown overnight at 37°C in 
a rotating incubator. 
2. 5ml of overnight culture was further Inoculated into 100ml LB + 1ml 1M MgCl2 + 
1ml 1M MgSO4 and incubated at 37°C for ~3-4 hours until OD600 reached 0.5-0.6 
3. The flask was placed on ice for 15 minutes. 
4. The sample was transferred to a pre-cooled micro-centrifuge tube and centrifuged at 
4°C, 2-4000 RPM for 10 minutes to pellet cells. 
5. The media was discarded and the pellet  re-suspended (on ice) in 33ml of cold RF1 
buffer (Refer to Appendix 2 for recipes for Buffers) 
6. The cells were incubated on ice for 1 hour. 
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7. After incubation, the cells were centrifuged at 4°C, 2-4000 RPM for 15 minutes to 
pellet. 
8. The RF1 buffer was removed and the pellet was re-suspended in 8ml of cold RF2 
buffer. 
9. The cells were incubated on ice for 15 minutes. 
10.  100-200µl aliquots were distributed into 1.5ml micro-centrifuge tubes and stored at -
80°C 
11. To confirm transformation efficiency in the newly competent cells, 50µl of cells were 
transformed with plasmid of known concentration i.e. 1µl of Puc19 (100pg/µl). After 
transformation, 450µl of NZY media was added to cells and 50µl (equivalent of 
10pg/µl) of the total volume was spread on selective media. (Refer to Bacterial 
transformation protocol below). The number of colonies were counted and efficiency 
was calculated by applying details to the transformation efficiency calculator: 
http://www.sciencegateway.org/tools/transform.htm 
2.1.2 Bacterial Transformation (XL1-Blue)
 
1. ≥0.1ng (generally 5ng) of DNA was mixed with 10-50µl of competent cells (x106) 
and incubated for 15 minutes on ice. 
2. The cells were then heat shocked for 60 seconds in a 42°C water-bath and cooled on 
ice for a further 2 minutes. 
3. 40-450µl of NZY media (refer to appendix 1 for recipe) was added and the cells were 
allowed to recover for 45 minutes at 37°C 
15 
 
4. After incubation the cells were spread on LB plate containing 100µg/ml of Ampicillin 
and incubated overnight at 37°C 
2.1.3 Large-scale preparation of plasmid (Midi prep) 
1. One colony of transformed E.coli cells were picked from agar and inoculated into 1ml 
of LB broth with 100µg/ml of Ampicillin. This was cultured in a 37°C rotating 
incubator overnight. 
2. 300µl of culture was transferred to 50ml of LB broth with 100µg/ml of Ampicillin 
and further incubated at 37°C for 3 hours or until OD650 0.8 was achieved. 
3. Plasmid DNA was extracted using a commercial Hi pure plasmid filter midi prep kit 
(Invitrogen).  The purified Plasmid DNA was re-suspended in 200µl of TE buffer 
(PH8). 
4. The DNA concentration was confirmed by either gel electrophoresis or by nanodrop 
spectrometer (ND-1000).  
2.1.4 Plasmids and Primers 
Selective primers used in this study were provided by a former PHD student (Wen, J 2010). 
Others were designed for this study using pombase and NCBI. 
The GFP 3’ivs and GFPivs reporter were cloned by digestion and purification of pREP GFP 
3’ivs or pREP GFPivs (provided by former PHD student (Wen, J 2010)) and ligated into 
pDUAL backbone (Wen, J 2010). The pDUAL based constructs would allow for digestion 
and integration into S. pombe for either stable or episomal expression.  
For a list of plasmids and primers used, refer to Appendix 3. 
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2.1.5 Standard PCR 
Buffer (5x)    1x 
DNTPs (25mM each)   200µM 
Primers (10µM)                                 0.2 µM   (0.1-0.5µM)                       
Enzyme (5U/µM)   1U/µl 
MgCl2* (25mM)                                 1.5mM 
Template                                            10-20ng 
St. ddH2O                                           made up volume (total mix: 20-50µl per reaction) 
*MgCl2 was only used in conjunction with GoTaq polymerase when GoTaq Flexi buffer was 
used (Standard Go Taq and Phusion buffer already contains MgCl2). 
 
The DNA polymerase that was routinely used was either GoTaq for checking or Phusion 
High Fidelity (FINNZYME) for cloning.  
For a list of primers used, refer to Appendix 3. 
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PCR program: 
25-30 cycles 
Initialisation   95°C  5min 
Denaturation   95°C            30sec 
Annealing                     -                30sec 
Extension                    72°C                - 
Final Extension           72°C            5min 
Final hold                     4°C                ∞ 
 
While certain parameters remain constant, Annealing temperature will vary, depending on the 
melting temperature (Tm) of the primers and the polymerase used (Phusion tends to be double 
that of GoTaq). Also the extension time varies depending on template size (i.e. GoTaq = 
1kb/min). Cycle number tends to be 25 for checking or 30 for other applications. 
The PCR reaction was run in a thermal cycler (2720/Applied Biosystems) and the amplified 
product confirmed by agarose gel electrophoresis. 
2.1.6 Colony PCR 
A fresh colony was picked and directly re-suspended in 25µl of PCR mix. Refer to standard 
PCR for details. 35 cycles was applied, in comparison to the standard PCR protocol and the 
initialisation step was increased to 10 minutes. This substituted the normal colony preparation 
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step (re-suspending the colony in water and heating to 95°C for 10 minutes prior to adding to 
PCR mix).  
The above protocol is not very efficient, for some applications it was necessary to treat the 
cell with Zymolase enzyme to ensure the cell wall is broken. 
1. Zymolase (10,000U/ml) was prepared in 1U/µl of 0.1M Sodium Phosphate Buffer 
(PH 7.4) and mixed thoroughly. 
e.g. 1µl Zymolase in 9µl Buffer  
2. A fresh colony was selected and re-suspended in the 10µl Zymolase/Buffer mix. 
3. The sample was incubated at 37°C for 20 minutes 
4. DdH2O was added to dilute the sample (~1:5) e.g. 40µl added to 10µl sample 
5. 5µl of diluted sample can be used per reaction as template DNA. 
2.1.7 Purification (PEG8000) 
1. As DNA is >300bp, an equal volume of PEG solution was added (if <300bp then 3x 
volume added) and sample was vortexed prior to centrifugation, 13000 RPM, RT for 
30mins (Eppendorf Centrifuge 5415R). 
2. The PEG was removed and the DNA was washed in 600µl of 70% ethanol (tube was 
inverted 3-4x). 
3. The sample was then centrifuged for 10 minutes, RT, 13000 RPM prior to removing 
the ethanol. This washing step was repeated for a second time. 
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4. After the ethanol was completely removed, the DNA was re-suspended in 16µl of 
either TE buffer or st.ddH2O. 
5. 1µl was run on a standard agarose gel to confirm quality and concentration of the 
DNA purified.  
2.1.8 Agarose Gel Electrophoresis (DNA) 
1. A 1% gel was prepared by adding 40ml of 1x TAE buffer to 0.4g agarose. 
2. This was heated until the agarose had fully dissolved and 2.5µl of ethidium bromide 
was added 
3. The solution was poured into gel cast/cradle with the addition of 10 well comb before 
the gel was left to set. 
4. Once the gel had set, the tank was filled to maximum line with 1x TAE buffer 
5. <20µl of sample and 2.5µl of 100bp or 1kb ladder was loaded onto gel and left to run 
at 90V for 30 minutes until sample reaches the bottom of the gel. 
6. The DNA/RNA was visualised using the chemi-doc (GeneGenius BioImaging 
System). 
2.1.9 Digestion 
1. Reporter DNA was digested in a total reaction mix of 50µl, consisting of 15µl of ~ 
0.5µg DNA, 1µl of SACII, 5µl of Buffer 4 and the volume made up with 29µl ddH2O. 
The digestion mix was incubated at 37°C for 1 hour 30 minutes. The digestion 
efficiency was confirmed by running 1µl on an agarose gel.  
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Note: Some restriction enzymes require heat inactivation to dissociate from the DNA. 
The tubes containing digestion mix are kept at 65°C for 20 minutes, and transferred to ice 
for two minutes prior to de-phosphorylation.  
2.1.10 De-phosphorylation of DNA 
De-phosphorylation of the 5’ end phosphate group of the plasmid will prevent re-
circularisation, providing the efficiency of the digestion is satisfactory. 
2. The 50µl volume of digested plasmid was mixed with 5µl of 10x buffer and 1µl of 
Antarctic Phosphatase. 
3. The DNA/enzyme mix was incubated at 37°C for 60 minutes 
4. After de-phosphorylation of the plasmid, the Antarctic phosphatase was heat 
inactivated to dissociate it from the DNA. The mix was incubated at 65°C for 20 
minutes and kept on ice for a further 2 minutes. 
2.1.11 Gel Purification 
1. 50µl of DNA was loaded onto a 1%  agarose gel and run for 30-40min at 90mV (refer 
to section: 2.1.8). 
2. DNA band was confirmed by size and the concentration noted prior to excision from 
gel using a clean blade and visualised by UV. 
3. The excised DNA is transferred to a clean, pre-weighed micro-centrifuge tube and re-
weighed to obtain weight of sample. 
4. DNA is purified by the Fermentas Silica Bead DNA Extraction Kit. 
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2.1.12 Ligation 
1. The ligation reaction was set up to a total reaction volume of 10µl, with a 1:10 molar 
ratio of vector:insert. T4 DNA ligase buffer was added 1:10 with T4 ligase added last 
in a 1:20 ratio and incubated overnight at 18°C.  
2.2 Yeast Culture (S. pombe) and Integration of Reporters 
Refer to Appendix 1 for EMM or YES liquid media and agar recipes. 
Wild-type strains were grown on inverted 9cm YES agar plates at 32°C, while transformants 
were grown either on EMM or YES agar plates in 25-32°C incubator (LMS Incubator) for 2-
3 days or as liquid culture, overnight in rotating 25-32°C incubator, 220 RPM (Innova 44 
Incubator Shaker Series). 
2.2.1 Strains 
See Appendix 3 for a list of strains used in this study. 
S. pombe Deletion Mutant Library (M3030H) 
The S.pombe Haploid Deletion Mutant Library was developed by Bioneer and KRIBB in 
Korea. The 3308 mutant strains were generated from the wild type strain SP286, by using 
PCR fragment-targeted mutagenesis to knockout most of the nonessential genes in the S. 
pombe genome. The haploid deletion library represents 92.8% coverage of nonessential genes 
in the genome. 
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Figure 2: Schematic of PCR fragment-targeted mutagenesis. The S. pombe Deletion Mutant 
Library was generated with gene knockout by KanMX4.  
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2.2.2 Integration of reporters into S.pombe 
In preparation for the Preliminary screen, GFP 3’ivs and GFPivs was integrated into 
SPJK001, a modified wild-type S. pombe (h+) strain, using SACII digestion and PEG 
purification.  GFP3’ivs and GFPivs was also integrated into wild-type (039), (H-) strain in 
preparation for screening the deletion mutant library. 
2.2.3 Yeast Transformation 
The strain used for transformation was inoculated primarily as pre-culture (in 1ml YES, 33°C 
O/N) and re- inoculated (100-200µl) in 5-8ml of YES media and grown O/N at 33°C in a 
rotating incubator (Innova44 Incubator Shaker System) until OD650 of 0.3-0.6 was reached 
(cell density of 1x10
7
 was confirmed by cell counting using Haemocytometer). 
The cells were rendered competent by LiAC method 
1. Cells were harvested by centrifugation, 3000RPM, 21°C for 4 minutes.  All media 
was subsequently removed and the pellet was washed with LiAc by adding 500µl of 
0.1M (mixed gently). 
2. Cells were centrifuged 3000RPM, 21°C for 4 minutes and LiAc removed before the 
cell pellet was re-suspended in LiAc (100µl per cell pellet derived from 1ml of 
culture). 
3. 1-10µg DNA was added to 100µl of LiAc treated cells (1x108), 1µg for plasmid 
transformation, 10µg for integration). In addition, 2 µl of single-stranded carrier DNA 
(10mg/ml) was added and mixed gently. 
4. The transformation mix was kept at RT for 10 minutes before adding PEG3350 
(260µl of 50%, bringing final to 35%). 
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5. The transformation mix was kept at 30°C for 1hour (mixing after 30minutes to 
resuspend cells) and heat shocked for 30minutes in 42°C water bath. 
6. Cells were then centrifuged at 5000RPM, 21°C for 2min to pellet the cells and PEG 
was removed. 
7. The pellet was re-suspended in 1ml st.dd water and centrifuged for a further 2min. 
The water was poured off and the cells re-suspended in the remaining water (~100µl). 
8. The 100µl of transformed cells were spread on an appropriate selection plate and 
incubated at 33°C for 5-6 days or until colonies are established. 
2.3 Pilot Screen: Cross and Random Spore analysis 
In order to screen the haploid mutant library for potential NMD mutants it was essential to 
quickly and efficiently insert the GFP reporter construct into the 3308 strains in the library in 
preparation for screening. On a smaller scale, yeast transformation would have been the 
quicker option, however this was not plausible with such a large number of strains. The pilot 
screen was important for trouble shooting any unforeseeable complications that may have 
arisen during the large scale screen. To optimize this process, four strains were crossed on 
agar mating media, two reporter strains; SPJK001 (h+) integrated with GFP 3’ivs, and 
GFPivs (selection by leu-), and two mutant strains; SPJK030 (h-) with UPF1∆, and SPJK031 
(h-) with UPF2∆, knocked out by KanMX6 cassette pertaining G418 resistance.  However 
the methods used in the preliminary or pilot screen would also not be feasible on a large 
scale. To increase the efficiency for screening of the entire library, the protocol required 
optimisation (2.4 Large Scale Screening of Haploid Deletion Mutant Library).  
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2.3.1 Cross (Pilot) 
1. Using a sterile toothpick, a visible quantity of the first strain (i.e. mutant strain) was 
scraped and transferred to a small region on the mating plate (SPAS) ~5mm diameter.  
2. Using a new toothpick, an equal amount of the second strain (reporter strain) was 
transferred to the same region and gently mixed. 
3.  5µl of st.ddH2O was added to the patch, mixed and streaked out. 
4. Plates were Incubated (LMS Incubator) at 25°C for 3-4 days or until colonies were 
visible. 
2.3.2 Random spore analysis (Pilot) 
1. When colonies were visible, 3 colonies were scratched and re-suspended in 20µl of 
st.ddH2O. 
2. 5µl was diluted ¼ with st.ddH2O 
3. The percentage of spores present were estimated by counting the cell number (total of 
vegetative cells and asci) on Haemocytometer. Then calculated by the total number 
per 15µl (remaining from dilution). Example: 20,000 cells present with ~20% of these 
being asci. 
4. The number of spores plated, were calculated based on the percentage of spores 
present in the remaining 15µl diluted culture. For example: If 15µl contained ~4000 
asci, the culture would give rise to ~16000 spores. If we assume that only half may 
grow (due to heat treatment), and that of the remaining 8000 spores only ¼ will be 
correct then we would expect to give rise to 2000 potentially correct colonies. 1000 
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colonies is sufficient, therefore 7.5µl would be required (volume could be made up to 
100µl with dd H2O for ease of spreading). 
5.  1ml of culture was heated at 55°C for 30min to destroy vegetative cells 
6. The remaining spores were Spread on selective media (YES +G418 plate) and 
incubated at 32°C for 3-4 days or until colonies had grown.  
7. Once cells had grown, colonies were replica plated on EMM Leu- and incubated for a 
further 2 days. 
8. To confirm haplotype, cells were checked by colony PCR and verified by 
fluorescence microscopy to confirm reporter was working correctly within the strain. 
 
2.4 Large Scale Screen of Haploid Deletion Mutant Library 
As above mentioned the protocol used for the pilot screen required modification to improve 
efficiency and handling of large numbers of yeast strains. During mating, the reporter strain 
SPJK039 (h-) containing GFP 3’ivs and mutants from the Bioneer library (M3030H) (h+) 
required two different methods for plating. The reporter strain would need to cover a large 
surface area to allow for mating of multiple mutant strains on a single plate. While these 
numerous mutants would need to cover a smaller surface area to maximise the number of 
strains plated, while minimising the risk of cross-contamination. It is also important that these 
strains make sufficient contact with the reporter strain, therefore the liquid:colony ratio for 
cell number was optimised, specifically the volume of reporter to be plated. During the 
process of random spore analysis it became apparent that heating individual strains in water 
to kill the vegetative cells would be too laborious during the large scale mating, instead the 
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heat shock process was optimised for strains while still cultured on agar mating plates prior to 
replicating onto selective media. 
2.4.1 Large Scale Cross 
1. The reporter strain was grown in 1ml of overnight culture to OD650 of 1.0.  150µl of 
culture was spread on SPAS agar plate using 20 glass beads and allowed to part-dry. 
2. The mutant strains were transferred (48 strains per 9cm agar plate) from the same 
array on YES+ G418 stock plates (cultured from 96 well glycerol stock plates) to the 
SPAS mating plate using a 48 pin multi-blot replicator. On contact with agar/reporter 
strain, the replicator pin was rotated very slowly within the defined region.  
3.  Plates were Incubated (LMS Incubator) at 25°C for 3-4 days or until spores develop. 
2.4.2 Large scale Random Spore Analysis 
1. After 3-4 days, one mutant per plate was checked under the microscope to confirm 
sporulation. 
2. If asci were present, plates were heat shocked at 75°C for 40minutes to destroy 
vegetative cells. 
3. Once plates had cooled to RT, spores were transferred to selective media (YES+G418 
initially) by replica plating by velveteen squares and incubated at 32°C for 3-4 days or 
until colonies were visible. 
4.  Colonies were replica plated on EMM Leu- plate for further 3 days 
5. The strains were screened by fluorescence microscopy (see section: 2.5 Microscopy). 
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2.5 Microscopy 
2.5.1 Pilot Microscopy  
1. The S.pombe cells containing the reporter constructs were grown in 1ml EMM leu- 
media, 32°C O/N in a rotating incubator (Innova44 Incubator Shaker System) until 
OD600 of 0.8-1.0 was reached. 
2. 200µl of overnight culture was centrifuged (Eppendorf centrifuge 5415 R), 2000 
RPM for 1 minute to pellet the cells. 
3. After discarding the media, the pellet was washed by re-suspending in 200µl of 
ddH2O. 
4.  Further centrifugation was required at 2000RPM for 1 minute to pellet the cells. 
5. After discarding the water, the pellet was re-suspended in 20µl of ddH2O. 
6. 3µl of the cell suspension was transferred to a slide and cover-slip ready for viewing 
under Nikon Ti Eclipse fluorescence microscope. 
7. DIC images were taken for each and GFP was visualised by FITC, with an exposure 
time of 500ms for integrated strains or 90ms for episomal expression. The Gain used 
was set at 100. 40X objective was used for initial screening and optimisation. 
Note: this protocol was adapted for use in the final round of screening (for 100X 
images of 18 strains), as OD600 0.2-0.3 was used for RNA extraction, the culture for 
these images was also grown to this OD. 
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2.5.2 Microscopy for Large Scale Screening 
As with any mutant strain there will be additional phenotypes associated with the particular 
deletion, such as growth defects. Due to the large number of strains being handled it was not 
possible to adjust for this time factor. Ideally, and time permitting, the library would have 
been re-screened, taking into account the longer culture time required for these sick strains. 
1. The strains were transferred by scraping a visible amount from agar plates containing 
the progeny of the crossed mutants with the reporter strain and directly re-suspended 
in 50µl of selective media (PMG) in 96 well Corning plates. These plates were black 
polystyrene/clear non-binding surface for microscopy.  
2. DIC images were taken for each strain and GFP was visualised by FITC, with an 
exposure time of 500ms for integrated strains or 90ms for episomal expression. The 
Gain used was set at 100. The objective used with these plates was 20X during 
screening. 
2.6 Verification of Mutants and Molecular Analysis of Protein and RNA 
Levels 
To confirm that the strains provided by BIONEER were correct, any putative strains 
identified in the screen should be confirmed by PCR using primer specific for each mutant.  
The control strains used for this study, wild-type and UPF1∆ containing the reporters were 
confirmed by western blot analysis to compliment the fluorescence microscopy, although this 
method would not necessarily be used for quantification purposes. 
For verification and quantification that the gene deleted, was exhibiting reduced NMD, in 
those putative mutants identified in the screen, northern blot analysis was performed to 
confirm the effect on RNA levels.  
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2.6.1 Genomic Extraction 
1ml of pre-culture was inoculated into 3ml YES and grown overnight. The Genomic DNA 
was extracted using the Qiagen: Puregene yeast/bact Kit B and the concentration confirmed 
by agarose-gel electrophoresis.  
2.6.2 Protein extraction (for S.pombe) 
1. 1ml of overnight culture was grown at 37°C in either EMM leu- or YES 
2. The overnight culture was centrifuged at RT, 3000 RPM for 3 minutes to pellet the 
cells. 
3. The media was removed prior to washing the cells by re-suspending pellet in 500µl 
ddH2O and centrifuged for a further 3 minutes to pellet cells 
4. The water was removed and the pellet re-suspended in 300µl of fresh ddH2O. 130µl 
of 1M NaOH was added to make a final concentration of 0.35M. 
5. The sample was incubated at RT for 5-10 minutes prior to centrifugation at 4°C, 8000 
RPM for 3 minutes. 
6.  The NaOH was removed and the pellet re-suspended in 50µl of 1x SDS loading 
buffer containing 1:25 B-mecaptoethanol and 1:1000 PMSF 
7. The sample was boiled for 6 minutes, then cool on ice for 2 minutes before 
centrifugation at 4°C 13,000 RPM for 2 minutes 
8. The sample was loaded onto a polyacrylamide gel. 
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2.6.3 Sodium-dodecyl-sulfate Polyacrylamide Gel Electrophoresis 
1. The resolving and stacking gels were prepared without the addition of TEMED to the 
latter until ready to pour (see appendix 2). 
2. The apparatus was set up as per manufacturer’s instructions (BioRad) and 500ml 1x 
SDS-running buffer prepared 
3. 10-20µl of samples and 7µl of marker were loaded onto gel and run for initial 5 
minutes at 50V until samples pass through the stacking gel, then for further 2 hours at 
90V. 
4. When samples had resolved the gel was removed from the apparatus and over laid on 
2x moistened filter paper. Nitrocellulose membrane was added to the stack with the 
addition of 2x filter papers and placed between sponges prior to inserting into cassette 
for protein transfer. 
5. The cassette was inserted into transfer tank with 500ml cold transfer buffer and run at 
350mA for two hours. 
6. After transfer, the membrane was incubated in blocking solution, at RT for 30 
minutes with gentle agitation. 
7. Subsequently, the blocking solution was replaced with primary antibody (either 
monoclonal or polyclonal anti GFP) 1:2000 in TBST and incubated at 4°C overnight 
with agitation. 
8. The excess antibody was removed by washing the membrane 2x in 15ml TBST 
briefly, followed by 3x at 10 minute intervals. 
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9. After washes, the membrane was incubated in secondary antibody (1:10,000) in 
TBST for 1 hour at room temperature with gently agitation (either anti-mouse or anti-
goat depending on whether monoclonal or polyclonal 1° antibody was used 
respectively). 
10. Washing step 8 was repeated. 
11. TBST was removed and the membrane incubated in 1ml ECL substrate (500µl of 
each; luminol and pico stable peroxide per membrane) at RT for 5 minutes. 
12. The membrane was wrapped in saran wrap and exposed using chemi-doc (G.BOX 
Syngene). 
2.6.4 RNA Extraction 
1. Yeast cells were cultured in 10ml volume of selective media to OD600 =0.3-0.8 (OD 
0.3 appears optimal for expression of this reporter). 
2. cultured cells were centrifuged for 5 minutes at 4.5K RPM in tabletop centrifuge at 
4°C to pellet cells. 
3. The supernatant was discarded and pellet re-suspended in 1ml of cold water prior to 
transfering to 1.5ml micro-centrifuge tube. Cells were centrifuged for 10 seconds at 
4°C to pellet. 
4. The supernatant was removed and cells re-suspended in 600µl of TES solution. 600µl 
of acid phenol was added and vortexed vigorously (10 sec). 
5. Samples were incubated for 40 minutes at 65°C, with vigorous vortexing every 10 
minutes. 
6. Samples were cooled on ice for 5 minutes and centrifuged for 5 minutes, 13.2K RPM 
at 4°C 
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7. The aqueous phase (top layer) was transferred to a clean micro-centrifuge tube 
containing 600µl of pre-cooled acid phenol and vortexed vigorously. Step 6 was 
repeated. 
8. The aqueous phase was transferred to clean micro-centrifuge tube containing 600µl of 
pre-cooled chloroform. The samples were vortexed vigorously and micro-centrifuged 
for 5 minutes, 13.2K RPM, at 4°C. 
9. The aqueous phase was transferred to a clean micro-centrifuge tube containing 1/10 
the volume of pre-cooled sodium acetate PH 5.3 (i.e. 36µl to 360µl aqueous phase), 
and 1ml cold 100% ethanol to precipitate for 20-30 minutes at -20°C. 
10. The samples were micro-centrifuged for 5 minutes, 13.2K RPM at 4°C and the 
supernatant removed. 
11. The RNA was washed in 1ml cold 70% ethanol, by vortexing briefly. Step 10 was 
repeated. 
12. RNA was air-dried to ensure no residual ethanol remained. 30-50µl of DEPC-treated 
water was added and samples kept on ice for 15 minutes prior to re-suspending. 
13. The concentration was determined by spectrophotometry by measuring the A260 and 
A280.  
2.6.5 Northern Blot Analysis 
1. 1.2% formaldehyde gel (120ml volume) was prepared by dissolving agarose in 
DEPC-treated H2O firstly, and allowed to cool prior to adding additional components. 
Agarose  1.44g 
DEPC H2O  85ml 
 
Formaldehyde  23ml 
10x MOPS  12ml 
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Running Buffer: 1X MOPS 
2. RNA samples were prepared as follows; 
RNA sample  10µg of RNA (unless conc is low, if require >8µl then only use 
5µg) 
Formaldehyde  5.5µl  
Formamide  15µl (or ~50% of total) 
10x MOPS  3µl (1X) 
3. Samples were incubated at 65°C for 15 minutes then ice for 5 minutes 
4. The gel was pre-run  for 5 minutes at 80V 
5.  1µl of loading buffer was added per sample and loaded on formaldehyde gel. This 
was run at 80V for 2 hours and 30 minutes (3-4 volts/cm) 
6. For blot transfer, the excess gel was trimmed and washed 2X with DEPC-treated H2O 
for 20 minutes followed by 1X with 20X SSC for 30 minutes. 
7. The overnight blot was set up with 20X SSC to allow RNA to transfer to HYBOND 
membrane by capillary action. Blot consists of; 
1X HYBOND 12x12.5cm 
1x Whatmann filter paper bridge 23x12cm 
6x Whatmann filter paper 11.5x12cm 
5x sheets of white paper roll (folded to ~11.5x12cm) 
Green paper towel cut in half (3x thickness of white roll stack) 
8. For UV crosslinking, membrane was crosslinked 1x at 120J 
9. Membrane was subsequently washed 1X with DEPC-treated H2O for 5 minutes prior 
to methylene blue staining to check RNA and washed after with DEPC-treated H2O 
until excess stain was removed. 
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10. For pre-hybridisation, the membrane was incubated at 68°C (Stuart Scientific 
hybridization oven/shaker SI2OH) for 3-4 hours with 30ml hybsol containing 
250µg/ml heparin and 100µg/ml SSDNA. 
11. For overnight hybridisation at 68°C, a leucine (control) or GFP probe was prepared as 
follows; 
Probe      10-20ng/µl 
5X labelling buffer (Promega)  5µl  
DEPC H2O     ≤21µl 
12. The above mix was boiled for 3 minutes and cooled on ice for 5 minutes prior to 
adding the following; 
dNTPs (C-) (Bioline 25µM each)  1µl 
Klenow     0.5µl 
P
32
dCTP (Perkin Elmer 250µCi)  2.5µl 
13. The above mix was incubated at RT for 2-4 hours. 
14. After 4 hours the prepared probe was purified by column equilibration in a pre-
prepared screw cap column containing G50/STE. The probe was centrifuged for 6 
minutes at 5000 RPM in a bench top centrifuge (Eppendorf centrifuge 5415D) and the 
purified probe collected in a clean micro-centrifuge tube. 
15. After confirming level of radioactivity (cps) the purified probe was boiled for 5 
minutes and cooled on ice for a further 5 minutes. 
16. After re-confirming radioactivity the purified probe was added to hybridisation buffer, 
consisting of 20ml hybsol, 250µg/ml heparin and 100µg/ml SSDNA 
17. The pre-hybridisation buffer was replaced with the above hybridisation buffer 
containing the probe and incubated overnight with the membrane at 68°C. 
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18. After hybridisation, the membrane was washed at 68°C with 4x with 100ml 2X SSC 
and 0.1% SDS, for 2, 5, 30 and 30 minute washes respectively. 
19. The membrane was washed for a final time in 100ml 0.2X SSC and 0.1% SDS for 30 
minutes at 68°C before confirming radioactivity. Generally the cps for GFP was high 
enough for 4 hour exposure (50+), however the leucine control was much weaker (20-
30 cps) and required overnight exposure. 
20. The film was developed using a BIO-RAD molecular imager. 
21. To strip the membrane (for re-hybridisation with a second probe), the membrane was 
boiled for 5 minutes in 0.1% SDS and left to cool to RT. The radioactivity was 
confirmed, if lower than 5 cps then pre-hybrdisation (step 10) was initiated. 
2.7 Functional analysis of putative mutants 
2.7.1 Pombase 
Pombase is a resource (www.pombase.org), offering structural and functional information of 
S. pombe genes. Using the systemic ID provided by BIONEER with the M3030H library, of 
the putative mutants identified from the screen, it was possible to search the database to 
confirm gene name (if characterised), functional and localisation information. Prior to 
pombase, GeneDB was used as reference (www.old.genedb.org/genedb/pombe/). 
2.7.2 BioGrid 
Biogrid (www.thebiogrid.org) is a repository for interaction datasets and provides protein and 
genetic interactions published in the current literature for a number of model organisms. 
2.7.3 STRING 
STRING database (www.string-db.org) offers both known and predicted protein interactions 
through direct or indirect associations, obtained from the literature (textmining and 
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databases), coexpression, genetic fusion and neighbourhood experiments, it also provides 
levels of confidence and summary networks.  
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CHAPTER III: RESULTS 
3.1 NMD Reporter Constructs  
Before performing the screen, I had to construct and test a number of GFP reporter constructs 
with or without NMD features (Fig. 3). The key feature of these constructs was the presence 
of an intron in the 3’ UTR, located just downstream of the GFP normal stop codon. Two 
standard S. pombe expression vectors were used: plasmids pREP and pDUAL (Maundrell K 
1993; Matsuyama, A et al., 2004). 
Both plasmids allow either episomal expression or integration into the genome by 
homologous recombination. As detailed below, two versions of these reporters were 
generated.  
3.1.1 GFP-3’ivs and GFP-ivs 
One of the reporters used was GFP-3’ivs (Fig. 3: C); this contains a 370 bp long intron in the 
3’ UTR, immediately after the normal termination codon, subsequently rendering its mRNA 
an NMD substrate (Wen and Brogna, 2010). When GFP-3’ivs is expressed in wild-type cells, 
GFP levels are very low (Fig. 4: A, right panel). In UPF1/2∆ strains however, the transcript 
level is rescued and GFP expression increased (Fig. 4: A, left panels). The level of GFP in the 
NMD mutants is similar to that of the control (GFP-ivs, data not shown) that does have the 
intron situated in the middle of the coding reading, position 110; this construct does not 
trigger NMD, in neither wild-type nor in UPF deletion strains (Wen and Brogna, 2010). As a 
second GFP reporter lacking both PTC and intron produced similar results (data not shown).  
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3.1.2 GFP147-3’ivs and GFP147 
Because GFP-3’ivs, started giving inconsistent results – it was extensively characterised, 
subsequently re-cloned and partially sequenced, but still, for unknown reasons, produced 
inconsistencies. As a result, a second set of reporters was used in the later stages and for the 
re-screening of putative mutants.  These second reporters were GFP147-3’ivs and GFP147 
(Fig. 3: E and D respectively) which are identical to GFP-3’ivs except for the addition of a 
spacer 147 bp in length, positioned immediately after the normal termination codon. These 
reporters produce the same expression phenotype as their predecessors, and were used for the 
late stage of the screening and for the Northern blot analysis of the putative mutants.
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Figure 3: Schematic of Reporters 
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Figure 3: Schematic of NMD reporters and controls 
A) Schematic of the GFP control reporter containing GFP ORF, under the control of nmt41 
promoter and terminator. B) GFP-ivs construct, based on the same reporter as GFP, 
containing an intron, measuring 370bp in length, at position n110. This is not subject to NMD 
C) GFP-3’ivs, contains an NMD feature consisting of a 370bp intron insertion in the 3’ UTR 
immediately after the normal termination codon. Due to the position of the intron insertion, 
the termination codon will be interpreted as a premature termination codon. D) GFP147, 
based GFP reporter with additional 147bp spacer inserted immediately after the normal 
termination codon. E) GFP147-3’ivs, based on GFP-3’ivs reporter, with a 147bp spacer 
inserted immediately after the normal termination codon and upstream of 3’ intron. 
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3.2 Preliminary Large Scale Screen of Haploid Mutant Library 
As previously mentioned, when integrated into wild-type S. pombe cells, the GFP-3’ivs 
reporter produces a very low level fluorescents, however, when integrated into an NMD 
mutant strain, the level of GFP mRNA and the subsequent protein expression are restored to 
control levels comparable to GFP reporters not subjected to NMD. The expectation is that in 
the absence of a gene required for NMD, there will be an increase in the level of GFP 
expressed in relation to wild-type, and potentially comparative levels to those produced in the 
UPF1∆ strain.  
For the screen, the reporter construct GFP-3’ivs was firstly integrated into wild-type 
(SPJK039 h-) cells which were subsequently mated with mutants derived from the haploid 
mutant library (Bioneer, M3030H h+ Version 3). The progeny were selected for leucine 
prototrophy and G418 resistance to confirm integration of construct into ∆ mutant strain prior 
to screening. Due to time limitation, of the total 3308 non-essential mutants from the deletion 
mutant library, 2790 strains have been screened using the integrated GFP-3’ivs reporter for 
increased GFP fluorescence in comparison to wild-type, and comparable to a known NMD 
factor, UPF1∆. 
Following two rounds of screening, eighteen putative mutants were identified (Fig. 4, panels 
A to R show pictures taken in under the same conditions).  In these strains GFP fluorescence 
was consistently higher than that in wild-type. In some of the strains (panels A, B, G, H, I, J, 
Q, and R) fluorescence appears only marginally higher than wild-type in the pictures yet the 
difference was apparent under the microscope and so were included for further analysis. Some 
of the strains show high level of fluorescence only in a fraction of cells, with >90% of cells 
having no GFP expression and <10% exhibiting very strong GFP. We cannot rule out a cross 
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contamination; these strains will need to be confirmed by PCR to eliminate this possibility. 
While screening, the level of GFP was noted for both the cytoplasm and the nucleus, with the 
former less intense. Also the level of background GFP was taken into account, and 
confounding variables such as cell number were addressed, after optimisation this variable 
was dismissed as having a very insignificant effect on the level of background GFP observed.  
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Figure 4: GFP-3’ivs integration 
A) GFP expression in wild-type and UPF1/2∆ strain 
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B) Screening of Haploid Deletion Mutant Library 
  
SPAC3A12.08 GFP SPAC343.20 GFP 
SPAC25G10.06 GFP SPAC27E2.01 GFP 
SPAC630.15 GFP SPAC652.01 GFP 
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Figure 4: Mutant strains showing enhanced expression of GFP3’ivs 
SPCC757.02c GFP SPAC8C9.09c GFP 
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A) GFP expression in wild-type and UPF1/2∆ strain. GFP expression in the wild-type S. 
pombe cells integrated with GFP-3’ivs reporter show little fluorescence due to the NMD 
feature of the construct. In both positive controls; UPF1∆ and UPF2∆ strains, the GFP levels 
are restored due to the abolishment of NMD.  B) Screening of haploid deletion mutant library, 
all strains pictured, show a level of GFP higher than that of wild-type, however lower when 
compared to both positive controls. 
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3.3 Secondary Screen of Putative Mutants using GFP147-3’ivs 
Following the initial screen, we thought to further test the putative mutants with a secondary 
screen in which I used the GFP147-3’ivs NMD reporter, which as described above behaves 
similarly to the GFP3’ivs used in the initial screen. Thus any potential NMD factor can be 
screened based on an increase in the level of GFP expressed in relation to levels in the 
GFP147 control strains that does not carry a 3’UTR intron. 
This time the GFP reporter expressed episomally with a pREP-based vector (Maundrell 
1993). The advantage of using plasmid expression vector is the increase in quantity of mRNA 
produced (and therefore GFP protein) which is more abundant than the single copy-integrated 
GFP-3’ivs, this is advantageous for both microscopy and northern blot analysis. However, 
there are two significant drawbacks, firstly, despite this construct containing an NMD feature, 
it is a less preferential substrate due to the presence of a spacer which extends the distance of 
the intron from the stop codon, as a result the mRNA levels are higher than those produced in 
wild-type strains with GFP-3’ivs (Wen and Brogna, 2010). Secondly, unlike its integrated 
counterpart, copy number is an additional variable of episomal expression of the GFP147-
3’ivs construct, making it slightly more difficult to judge the levels of GFP between strains, 
by microscopy. It can however be easily be quantified by Northern blot analysis, using the 
plasmid leucine marker to account for plasmid copy number variation.  
Of the 18 putative strains re-screened with GFP147-3’ivs, 9 strains expressed levels of GFP 
comparable to the same strains expressing GFP147 (Fig. 5:B).  These 9 strains are shown in 
panels: B, G, H, I, K, L, O, P, and R. The strains were selected based on whether the nucleus 
(a easy to distinguish feature) exhibited strong GFP fluorescence, in addition to a less intense, 
cytoplasmic fluorescence, which was comparable to that of the GFP147 equivalent. This 
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method of screening was difficult due large cell-to-cell variation in fluorescence in some 
strains. For instance, Fig. 5:B, C, D, and E had comparable levels of GFP, however about 
10% of the cells show much higher fluorescence. It is not clear why there is such large 
difference in GFP levels. One possibility could be due to copy number, as previously 
mentioned, some cells, despite being a potential candidate for further study, simply does not 
have sufficient copies of the plasmid, thus some cells express lower levels of GFP. 
Alternatively these strains may be valid, however due to the stage in their cell cycle or other 
confounding variable, only a small proportion of cells in the correct stage, appear positive. As 
such these negative strains were not immediately discounted, instead all 18 strains were 
examined by northern blot analysis to confirm.  
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Figure 5: Episomal expression of GFP147-3’ivs  
A) Wild-type and UPF1∆ controls 
 
 
 
 
 
B) Screening of putative mutants from Haploid Deletion Mutant Library 
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Figure 5: Secondary screen confirmation of putative NMD mutants.  
A) GFP fluorescence in wild-type and UPF1∆ controls. Episomal expression of GFP in the 
wild-type S. pombe cells from GFP147-3’ivs reporter, show little fluorescence due to NMD. 
In UPF1∆ strain, the GFP levels are restored due to the abolishment of NMD.  B) Screening 
of putative mutants from haploid deletion mutant library. The second column (X’), shows 
FITC images for 18 putative mutants transformed with GFP147-3’ivs reporter and the first 
(X) the corresponding DIC image. The fourth column shows FITC images of strains 
containing GFP147, and the third, DIC. Of the 18 strains pictured (A-R), 9 mutants show a 
level of GFP comparable (GFP147-3’ivs: X’) to the control reporter within the same strain. 
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3.4 Quantification of putative mutants by northern blot analysis  
 
As previously mentioned, unlike its integrated counterpart, copy number is an additional 
variable of episomal expression of the GFP147-3’ivs construct, making it slightly more 
difficult to compare by fluorescence microscopy the levels of GFP between strains.  
As such the sub-library of putative candidates selected by first round of screening (initially by 
GFP-3’ivs), were analysed by Northern blot analysis to provide quantification of the levels of 
mRNA. Total-RNA was extracted by hot phenol method from strains episomally expressing 
GFP147-3’ivs. The strains were derived from primary cultures of those used previously for 
screening by microscopy and grown to OD600 0.3. This OD is lower than typically used, 
however at higher OD there tends to be more variation in RNA obtained from the same 
cultures (based on observations in control strains; wild-type and UPF1∆). The level of the 
leucine mRNA was used to correct for plasmid copy number variation. 
Of the eighteen putative strains analysed, seven strains showed restored levels of RNA (50% 
of GFP147 control) in both rounds of Northern blot (Fig. 6). The quantifications given are 
(%) averages based on data from both experiments, thus some of the values may not best 
represent the band pictured.  Due to time constraints it was not possible for a third repeat, as 
such, no statistical analyses could be performed. 
Three strains showed increased mRNA level for only one round: SPAC27E2.01, SPAC652.01 
and SPAC869.11 (Fig.6: lanes 8, 16 and 42) and have been excluded as putative NMD 
mutants in this study. The reason for this variation is unknown, however one possibility could 
be due to difficulties with quantification of data from the second round of Northern. This is 
because there are two bands present following hybridisation with the leucine probe (refer to 
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Fig.6); the lower band is approximately ¼ the intensity of the higher band it is possible that 
the additional band correspond to residual GFP. As a result, subtracting the background for 
quantification was more difficult. Subsequently, normalization and quantification for difficult 
bands were based on peak data, opposed to the more representative trace data normally used. 
This could account for some variation in the values between blots for the same strains. 
A third repeat would have been beneficial to establish the significance of the data obtained, 
and they may be worth re-visiting for any future work, particularly for strain SPAC27E2.01 
(Fig. 5B and Fig. 6, lane 8), as this tested positive by all microscopy based screens, and 
confirmed by one round of Northern blot analysis.  
Eight strains; SPAC3A12.08 (Fig. 6, lane 12), SPAC630.15 (14), SPAC19B12.10 (18), 
SPBP8B7.18c (20), SPBC8E4.03 (22), SPCC1223.02 (30), SPCC757.02c (34), and 
SPCC1739.01 (44) exhibited levels of RNA less than 50% of control in both rounds of 
Northern. These were 21%, 29%, 37%, 34%, 40%, 40%, 35% and 31% respectively, and as 
such have been discounted. Some of these strains, however, show an apparent GFP increase 
phenotype - SPAC19B12.10 (Fig. 5B: G), SPBP8B7.18c (H), SPBC8E4.03 (I), SPCC1223.02 
(K), and SPCC1739.01 (R), suggesting that GFP protein levels are similar to that of the 
NMD-insensitive GFP147 control. 
Thus, seven strains were confidently identified as NMD mutants in both rounds of Northern 
blot: SPAC25G10.06 (Fig. 6, lane 6), SPAC343.20 (10), SPBP35G2.08c (24), SPAC22G7.03 
(32), SPAC8C9.09c (36), SPBC32F12.12c (38) and SPBC21H7.07c (40). These showed 
levels of GFP mRNA similar to that of GFP147 and UPF1 deletion: mRNA levels were 74%, 
76%, 99%, 99%, 99%, 63%, and 59% respectively.  Of these, three strains - SPAC22G7.03 
(Fig. 5B: L), SPBC32F12.12c (O) and SPBC21H7.07c (P) - were consistently positive 
58 
 
throughout all rounds of screening and concurrently had restored levels of RNA and protein 
from the NMD substrate. In conclusion, these seven strains resulted in suppression of NMD. 
Whether, this is due to abolishment of NMD or some indirect effect needs to be investigated.  
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Figure: 6. Quantification of putative NMD mutants by Northern blot.  
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Figure 6: Quantification of putative mutants by northern blot. 
Northern blot analysis of GFP mRNA in the putative NMD mutants identified in the 
microscopy screen. GFP bands were normalised against leucine to correct for plasmid copy 
number variation. The quantifications given are (%) averages based on data from two 
independent RNA samples. The quantification was done using the QuantityOne software of 
images acquired with a Bio-Rad phosphorimager. 
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Figure 7: Table of putative mutants; function, localisation and summary of results.  
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CHAPTER IV: DISCUSSION 
4.1 Putative NMD Mutants Identified in the Screen 
Despite the vast amount of research into the process of NMD, our understanding of this 
mechanism is still not satisfactory. It is possible that different mechanisms have arisen across 
species, particularly following the observation that splicing-dependent NMD is independent 
of the EJC in S. pombe (Wen and Brogna, 2010). This highlights the fact that the EJC model 
cannot provide an explanation for this nucleus-cytoplasmic link in all systems where such link 
has been reported. This study aimed to identify any additional factors that may exist in S. 
pombe in an attempt to unveil the mechanisms behind these observations. 
I have screened 2790 deletion mutants for increased GFP expression of an NMD sensitive 
reporter. Following two rounds of screening seven strains identified were: SPAC25G10.06 
(Fig. 5B:A/Fig.6 lane 6), SPAC343.20 (C/10), SPBP35G2.08c (J/24), SPAC22G7.03 (L/32), 
SPAC8C9.09c (N/36), SPBC32F12.12c (O/38) and SPBC21H7.07c (P/40). Here I provide 
additional information about these genes and some preliminary bioinformatics analysis. 
4.1.1 SPAC25G10.06 (rps2801/rps28-1) 
A ribosomal protein was identified during the screen, which due to the central role of the 
ribosome in NMD induction, it would be expected that some ribosomal proteins (RPs) would 
be involved in this process, particularly with the recruitment of NMD factors to the 
terminating ribosome. This gene, rps2801/rps28-1, encodes for the ribosomal protein S28, 
which is a structural constituent of the small 40S subunit of the ribosome (Pombase). 
Interestingly, the human homolog of S28 is RPS23 associates with HNRNPU (heterogenous 
nuclear ribonuclearprotein U) or scaffold attachment factor A. HNRNPU is a spliceosome 
component and part of the coding region determinant (CRD)-mediated complex that was seen 
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to promote MYC mRNA stabilisation (Hüttelmaier 2009). It should however be noted that 
there are no known HNRNPU homologues in yeast, although it would be interesting to 
investigate further whether the link between splicing and NMD in yeast is facilitated by other 
components that are mediated through RPS28, and may have a similar role to HNRNPU. 
Using the String database (www.string-db.org) I find evidence of interactions between S28 
and snu13 (SPAC607.03c) in S. pombe; this is a U3 snoRNP-associated protein that is 
associated with the U4/U6-U5 snRNP tri-snRNP (Stevens and Abelson, 1999).  
4.1.2 SPBP35G2.08c (air1) 
The zinc knuckle protein, air1, is a component of the TRAMP complex (Trf4p/air2p/mtr4p 
polyadenylation complex) which is a multi-protein complex consisting of air1p or air2p, an 
RNA helicase (mtr4p), and a poly (A) polymerase (either trf4p or trf5p) (Corbett et al, 2011). 
This complex operates in the nucleus and nucleolus and is implicated in nuclear RNA 
processing and degradation (Biogrid). Substrates include aberrant pre-mRNA, rRNA, 
impaired tRNA methyltransferase, snoRNA, telomeric and cryptic unstable transcripts 
(CUTs) (Corbett, A et al 2011). Air1/2p is a critical component of the TRAMP complex that 
has a role in bridging mtr4p by its N-terminal domain to trf4p by its ZnK5 domain 
(Vanacova, S et al 2012).  In S. pombe, air1 interacts with cid14 SPAC12G12.13c, a poly (A) 
polymerase that is a functional ortholog of trf4/5 in S. cerevisiae suggesting that a TRAMP-
like complex does exist in S. pombe (Biogrid, Keller 2010). It has been observed that cid14 
co-purifies with a number of RPs, more specifically, interacting with the 60S ribosome 
subunits and associated assembly factors. As such it was inferred that cid14 may interact with 
ribosomal proteins during the assembly of the large subunit of the ribosome (Keller 2010).  
The role of air1/2 in mRNA surveillance may not be limited to TRAMP-exosome mediated 
degradation. UPF1 interacts with air2p and mtr4p in S. cerevisiae (STRING). Although there 
is no known interaction in S. pombe, Air1 and UPF1 are present in both species. The 
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information available for S. cerevisiae, does suggest a link between the TRAMP and NMD 
pathway. The TRAMP complex, however, is believed to work in the nucleus while NMD is 
thought to be a cytoplasmic process. Yet, the observation that splicing is linked to NMD in an 
EJC-independent manner does however leave open the possibility that perhaps NMD can 
occur in the nucleus. This view is supported by the observation that UPF1 and other ribosome 
related factors bind with chromatin-associated RNA in S. pombe
 
(De et al, 2011 and Brogna 
lab unpublished).  
4.1.3 SPBC32F12.12c (Golgi membrane protein)  
SPBC32F12.12c was identified as positive in all of my GFP microscopy screens and NMD 
suppression was confirmed by the Northern blot analysis. The gene encodes a Golgi 
membrane protein, involved in vesicle-mediated transport of secretary proteins to either 
vacuole/lysosome or the cell surface (Yoda et al., 2005). Bioinformatic analysis using Biogrid 
shows interaction with ARP42 SPAC23D3.09, also known as SWI/SNF, a nucleosome 
remodelling complex that allows transcription factors to access the chromatin, thus facilitating 
transcription. This complex has been implicated in a much wider set of cellular processes, 
other than gene expression, including centromere function and chromosome stability (Snyder 
2011). ARP42 has UPF1, UPF3, air1 and mrt4 as interaction partners (Biogrid), indirectly 
linking the Golgi membrane protein identified in this screen to both the TRAMP complex and 
NMD factors.  
4.1.4 SPAC22G7.03 (a sequence orphan) 
This gene has no apparent orthologs. The protein orphan is localised in both the nucleus and 
the cytosol. While there is little information available for this gene, as such, no explanation 
can currently be offered, and further investigation and characterisation is required. Having 
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searched for interaction partners in Pombase and Biogrid, SPAC195.06c, a spliceosomal 
complex unit was identified which may offer some insight, although with little more 
information, an in-depth hypothesis cannot be provided. In addition, par1, a protein 
phosphatase regulatory subunit and hrr1, a helicase required for RNAi-mediated 
heterochromatin assembly were also listed as genetic interaction partners. 
4.1.5 SPAC8C9.09c (mug129) 
Mug129 is also a sequence orphan with no apparent orthologs. It does appear to have genetic 
interactions with the ski complex subunit Rec14, which assists the exosome in 3’ end 
degradation of mRNAs and Arg1 (Argonaute), some of these proteins have endonuclease 
activity against mRNAs.  
4.2 Other putative NMD mutants 
These include SPAC343.20 (listed as dubious), which is believed to have a role in the cellular 
response to stress and currently there is no interaction data available for this strain in Biogrid. 
Additionally, SPBC21H7.07c (his5) an imidazoleglycerol-phosphate dehydratase, which is 
responsible for histidine metabolism, does not appear to have any interactions with factors 
involved in splicing nor decay pathways.  
4.3 Positive hits discounted after further analysis 
Eleven strains have been discounted following Northern blot analysis which did not indicate 
NMD suppression. These include: SPCC1223.02 (nmt1/thi3) a 4-amino-5-hydroxymethyl-2-
methylpyrimidine phosphate synthase and is understood to be involved in thiamine 
biosynthesis. It was identified as a fully repressible gene and has since been utilised as a tool 
through its use as an inducible expression system (Maundrell 1990). SPBC8E4.03 
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(Agmatinase 2) is implicated in urea and cellular amino acid metabolism. SPAC27E2.01 
(Alpha-amylase homolog) involved in cellular and extracellular polysaccharide metabolism.  
In addition; SPAC3A12.08 (Conserved fungal protein), SPAC630.15 (Mug177), SPAC652.01 
(BC10 family protein), SPAC19B12.10 (Sst2), SPBP8B7.18c (TENA/THI family protein), 
SPCC757.02c (Epimarase), SPAC869.11 (Cat1) and SPCC1739.01 (Zf-CCCH type zinc 
finger protein), were all excluded. 
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Figure 8:A. Protein interaction network for SPAC25G10.06 (rps2801/rps28-1) in S.pombe. 
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Figure 8:B. Protein interaction network for SPAC25G10.06 (rps2801/rps28-1), SPAC607.03c 
(snu13), SPBC146.07 (prp2), Smg1, Upf1 and UPF2 (top) and addition of 10 nodes (bottom), 
in S.pombe. 
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Figure 8:C. Protein interaction network for NAM7, NMD2, UPF3, air1, air2, and cwc21 in 
S.cerevisiae. 
71 
 
4.4 Problems with this Screening System  
As with any mutant strain there will be additional phenotypes associated with a particular 
deletion. In UPF1∆ strains, the cells are more elongated and tend to grow slower than wild-
type. Growth defects were very apparent while working with the deletion mutant library, with 
a number of strains that failed to grow. Additionally some mutants may be temperature 
sensitive, as such it is essential for these factors to be considered for any future work to 
eliminate the likely-hood of missing potential candidates, based on their disadvantaged 
phenotypes. 
4.4 Conclusions 
Due to time constraints it was not possible to screen all sets within the library and as such 
there may be additional NMD genes. Furthermore I did not screen essential genes. The screen 
I have described here in detail was based on splicing-dependent reporters, however, it will be 
informative to assay whether the mutants I have identified are able to suppress splicing-
independent NMD; for example in GFP-N6, a nonsense mutation introduced in the GFP 
coding region at residue 6, results in very strong NMD in wild-type cells (Wen and Brogna, 
2010). The prediction is that some of the mutants identified suppress only NMD of splicing-
dependent reporters. In future studies it will be necessary to further characterise the protein 
identified so to test for any direct or indirect binding with know NMD and mRNA decay 
factors. Finally, in view that some of the proteins I have identified that are known to be 
involved in nuclear processes, such as TRAMP nuclear mRNA surveillance, future studies 
should directly assess whether NMD is directly linked to nuclear events.  
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APPENDIXES 
Appendix 1: Recipes for E. coli and S. pombe media 
LB Broth 1L  
NaCl        10g 
Bacto-tryptene (Peptone)     10g 
Yeast extract       5g 
dd H2O       1L 
 
Adjust PH to 7.5 (with NaOH) 
Autoclave for 30 minutes at 121°C 
 
LB-Agar (plates) 1L 
Same as for LB Broth (see above)  
Bacto Agar (prior to Autoclaving)    20g 
 
 
YES Media (Arg+) 1L 
Yeast Extract       5g 
Sp complete supplements     1g 
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Arginine       0.112g 
Dd H2O       1L 
 
Autoclave for 30 minutes at 121°C 
 
YES-Agar (Plates) 1L 
Same as for YES Media (see above)  
Bacto Agar (Prior to autoclaving)    20g 
 
EMM Media (Leu- Arg+) 1L 
Pottassium Hydrogen Phthallate    3g 
Di-Sodium Hydrogen Orphaphosphate-2-hydrate  2.2g 
Ammonium Chloride      5g 
Sp Supplements (Leu- Ura-)     0.17g 
Uracil        0.112g 
Arginine       0.225g 
dd H2O       929ml 
 
Autoclave for 30 minutes at 121°C 
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Glucose (40% stock)      50ml 
Salt (50X stock)      20ml 
Vitamins (1000X stock)     1ml 
Minerals (10,000X stock)     0.1ml 
 
EMM-Agar (Leu-) plates 1L 
Same as for EMM (see above)  
Bacto Agar (prior to autoclaving)    20g 
 
PMG- selection Media (Leu-/G418+) 1L 
Potassium Hydrogen Phthalate 
Sodium Hydrogen Orphophosphate di-hydrate 
L- Glutamic Acid Mono Sodium Salt  
SP Supplements (Leu- Ura-)     0.17g 
Uracil        0.112g 
Arginine       0.112g 
dd H2O       924ml 
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PMG- Agar (Leu-/G418+) 1L 
Same as for PMG (see above)  
Bacto Agar (prior to autoclaving)    20g 
 
SPAS-Agar mating plates (1L)  
1%   Glucose    10g 
7.3mM  KH2PO4    1g 
SP supplements (complete)  45mg 
    Arginine    0.112g 
    Bacto Agar                               10g 
 
Autoclave for 30 minutes at 121°C 
    Vitamins 1000X                        1ml 
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Appendix 2: Solutions             
 
RF1 (250ml) 
100mM  RbCl                          3g 
50mM               MnCl2 x 4H2O             2.475g 
80mM               KAc                               1.96g 
10mM               CaCl2 x 2H2O                  0.368g 
15%                  Glycerol (100%)             37.5ml 
 
Adjust PH to 5.8 (with 0.2M Acetic Acid) 
Filter Sterilise  
 
RF2 (250ml) 
10mM   MOPS                             0.523g 
10mM                 RbCl           0.302g 
75mM                CaCl2 x 2H2O               2.76g 
15%                   Glycerol (100%)           37.5ml 
Adjust PH to 6.8 (with NaOH) 
Filter Sterilise 
83 
 
 
Stock solutions: 
Vitamins 1000X (100ml) 
4.2mM       Pantothenic acid                       0.1g 
81.2mM     nicotinic acid                              1g 
55.5mM       Inositol                                                 1g 
40.8uM            Biotin                                                   1mg 
 
Minerals 10,000X  (100ml) 
80.9mM        Boric acid                       0.5g 
23.7mM            MnSO4                                          0.4g 
13.9mM       ZnSO4.7H2O                                        0.4g 
7.4mM         FeCl2.6H2O                                          0.2g 
2.47mM         Molybdic acid                                      40mg 
6.02mM        Kl                               0.1g 
1.6mM           CuSO4.5H2O                        40mg 
47.6mM         Citric acid                                 1g 
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Salt 50X (500ml) 
0.26M            MgCl2.6H2O                  26.25g 
4.99mM      CaCl2.2H2O                        0.3675g 
0.67M       KCl                                 25g 
14.1mM           Na2SO4                             1g 
 
PEG (8000) 30ml 
NaAC        1.47g 
MgCl2.6H2O       0.036g  
PEG8000       7.86g 
ddH2O        ≤ 30ml 
 
PEG (3350) 50% 100ml 
Peg 3350                                                50g 
ddH2O                                                        100ml 
 
LiAc stock (0.3M) 
9.18g LiAc di-hydrate  
300ml ddH2O 
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Autoclave 
LiAc/TE 50ml 
0.1M LiAc                                                                      16.6ml of 0.3M 
20mM Tris HCl                                  1ml of 1M 
2mM EDTA                                                        200µl of 0.5M 
St.ddH2O                                               32.2ml 
 
Filter Sterilise 
 
 
Resolving gel: 10% for 20ml 
ddH2O                                                7.9ml 
30% Acrylamide                                                 6.7ml 
1.5M Tris (PH 8.8)                                     5ml 
10% SDS                                                     200µl 
10% APS                                    200µl 
TEMED (to be added only on pouring gel)          16µl 
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Stacking gel: 5% for 6ml 
ddH2O                                                    4.1ml 
30% Acrylamide                                           1ml 
1.5M Tris (PH 6.8)                       670 µl 
10% SDS                                               60µl 
10% APS                                               60µl 
TEMED (to be added only on pouring gel)     6µl 
 
TAE (50X) 1L 
Tris Base       242g 
Glacial Acetic Acid      57.1ml 
0.5M EDTA (PH 8.0)      100ml 
ddH2O        ≤ 1L 
Working concentration= 1X TAE 
 
20X SSC 1L 
3M NaCl       175.32g 
300mM Na Citrate      88.23g 
DEPC- H2O       ≤1L 
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Adjust to PH 7 with NaOH 
 
Hybsol 1L 
1.5X SSPE      75ml of 20X 
7% SDS      70g  
10% PEG 8000     100g 
DEPC-H2O      ≤1L 
 
10X MOPS Running Buffer 1L 
0.2M MOPS      41.2g 
80mM NaAc      26.7ml of 3M 
10mM EDTA      20ml of 0.5M 
DEPC-H2O      ≤1L 
Adjust PH 7 
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Appendix 3: Plasmids, Primers and Strains    
Plasmids 
 
 
 
 
Primers 
Primer 
Name Sequence Annotation 
PMP ACGGTAGTCATCGGTCTTCC 
sexual determinant 
(haplotype in S.pombe) 
PMM TACGTTCAGTAGACGTAGTG 
sexual determinant 
(haplotype in S.pombe) 
PMT AGAAGAGAGAGTAGTTGAAG 
sexual determinant 
(haplotype in S.pombe) 
SSP41 GGAATCCTGGCATATCATCA 
sequencing primer for 
pREP41 
W196 GGTCTGCTAGTTGAACGCT GFP.Q2.Rev 
 
Strains 
 
 
 
 
 
 
py114 SPJK001 
h+ ade6-210 arg3D his3D leu-32 
ura4D18 
Janet F. Partridge 
janet.partrigde@stjude.org 
py115 SPJK002 h- ade6-210 arg3D his3D leu-32 ura4D18 
 Janet F. Partridge 
janet.partrigde@stjude.org 
MR3567 SPJK030 h- Upf1::KanMX6, leu1-32 ura4D18 
Mol Cell Biol.2006 
September; 26 (17): 6347-
6356 
MR3569 SPJK031 h- Upf2::KanMX6, leu1-32 ura4D18 
Mol Cell Biol.2006 
September; 26 (17): 6347-
6356 
MR3570 SPJK032 
h- Upf1::KanMX6/Upf2::KanMX6, leu1-32 
ura4D18 
Mol Cell Biol.2006 
September; 26 (17): 6347-
6356 
M3030H 
SP286 
library 
h+/h+ ::KanMX6, ade6-M210/ade6-M216 
leu1-32/leu1-32 ura4D18/ura4-D18 Bioneer 
 
Plasmid name 
Marker in 
yeast 
Resistance in 
E.Coli Labelled Description 
pDUAL-
GFPivs leu1/ura amp p106 
GFPivs ORF cloned by 
BamH1 
pDUAL-
GFP3'ivs     p152   
pDUAL-M.N6     p131   
pDUAL-
M.GFP     p138-2   
 
